The 26 analysts offering 12-month price forecasts for Biogen Inc have a median target of 428.50, with a high estimate of 647.00 and a low estimate of 244.00. The median estimate represents a +31.00% increase from the last price of 327.10.
The current consensus among 33 polled investment analysts is to Hold stock in Biogen Inc. This rating has held steady since July, when it was unchanged from a Hold rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share $4.24
Reporting Date Oct 26
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.